Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Defyne Plastic Surgery Pioneers alloClae in Arizona: The First to Offer Revolutionary Regenerative Aesthetic Treatment


News provided by

Defyne Plastic Surgery

Mar 17, 2025, 05:26 ET

Share this article

Share toX

Share this article

Share toX

alloClae, the groundbreaking structural adipose filler
alloClae, the groundbreaking structural adipose filler

Defyne Plastic Surgery is revolutionizing body contouring as the first medical practice in Arizona to offer alloClae, a cutting-edge structural adipose filler.

SCOTTSDALE, Ariz., March 17, 2025 /PRNewswire-PRWeb/ -- Defyne Plastic Surgery is setting a new standard in the world of body contouring by becoming the first medical practice in Arizona to offer alloClae, the groundbreaking structural adipose filler that promises to transform the future of aesthetic procedures. This cutting-edge innovation presents a non-invasive, highly natural alternative to synthetic filler, providing patients with enhanced cushioning, volume, and support without the need for liposuction or fat harvesting.

"alloClae is a monumental leap forward in the realm of regenerative aesthetics," said Dr. Oren Tessler, MD, Founder of Defyne Plastic Surgery and a renowned board-certified plastic and reconstructive microsurgeon. "This innovation opens up a whole new world of possibilities for patients. Now, those who may not have enough of their own fat or simply don't want to undergo liposuction can still achieve flawless, natural-looking results without the need for a surgical procedure."

"alloClae is a monumental leap forward in the realm of regenerative aesthetics," said Dr. Oren Tessler, MD, Founder of Defyne Plastic Surgery and a renowned board-certified plastic and reconstructive microsurgeon.

Post this

alloClae stands apart as the first-ever structural adipose filler designed specifically for aesthetic body procedures. Unlike traditional synthetic fillers, alloClae is derived from donor fat cells, ensuring biocompatibility with the patient's body. The filler undergoes an exclusive five-step purification process, which preserves its natural growth factors, proteins, and collagen, facilitating superior tissue integration and long-lasting outcomes.

This pioneering treatment can be used both as a standalone solution for volume restoration or in combination with traditional fat grafting to offer patients the ultimate body contouring experience. Thanks to its unique honeycomb structure, alloClae delivers enhanced volume while preserving a soft, natural look and feel, making it ideal for treating areas like hip dips, buttock augmentation, and breast enhancement. It's also perfect for those seeking to address cellulite and contour deformities.

alloClae is especially beneficial for patients who want to:

Enhance body contours (e.g., hip dips, breast and buttock augmentation): alloClae can help smooth out irregular body areas, such as hip dips, or enhance curves like the breasts and buttocks, providing a more youthful and aesthetically pleasing shape without invasive surgery.

Correct cellulite and contour deformities: By promoting tissue regeneration and improving skin structure, alloClae can reduce the appearance of cellulite and address contour deformities, helping to create a smoother and more even skin surface.

Achieve natural volume restoration without the need to harvest fat: alloClae offers a non-invasive solution for restoring volume to areas like the face or hands, eliminating the need for fat harvesting, making it a convenient and less invasive option for volume enhancement.

Avoid synthetic fillers and artificial substances: As a natural, biocompatible treatment, alloClae avoids the use of synthetic fillers, ensuring a safer, more organic alternative for individuals looking to enhance their appearance without the concerns associated with artificial substances.

Unlike traditional cellulite treatments that offer only temporary improvement, alloClae when combined with other innovative technologies, targets the root cause of dimpling by reinforcing the skin's structure from within. It stimulates collagen production and cellular regeneration, leading to firmer, smoother skin and long-lasting, natural results.

"As the demand for regenerative, non-invasive aesthetic procedures continues to rise, alloClae represents a major step toward long-lasting, natural results," said Dr. Tessler. "The filler integrates seamlessly with the body's tissue, stimulating healing and regeneration through its powerful proteins and collagen. Patients can expect not only significant volume restoration but also improvements in skin texture and elasticity."

Defyne MD has long been a trailblazer in offering innovative, minimally invasive procedures that reduce the need for general anesthesia, thus lowering risks and recovery times. With the introduction of alloClae, Defyne MD continues to push the envelope in aesthetic medicine, ensuring its patients receive the latest and most effective treatments.

For more information about alloClae and to schedule a consultation, visit DefyneMD.com today.

More about Dr. Tessler and Defyne Plastic Surgery:

Dr. Oren Tessler, MD, is a board-certified plastic and reconstructive microsurgeon and the founder of Defyne, a Phoenix and Scottsdale-based practice transforming plastic surgery through minimally invasive, technology-driven solutions. Known for the proprietary Defyne Method, Dr. Tessler delivers personalized, regenerative results without general anesthesia, ensuring less downtime and natural-looking outcomes tailored to each patient's unique goals. With an MD/MBA from McGill University and advanced training at Harvard's Massachusetts General Hospital, Dr. Tessler combines expertise with innovation. His career highlights include over 30 publications, groundbreaking contributions like the first complete hand transplant at Massachusetts General, and a nomination to the American Society of Plastic Surgeons' National Autologous Breast Reconstruction Workgroup. At Defyne, he empowers patients with a holistic, patient-first approach to aesthetic care. For more information, visit DefyneMD.com.

Media Contact

Holly Morgan, Defyne Plastic Surgery, 1 4808886074, [email protected], https://defynemd.com/

SOURCE Defyne Plastic Surgery

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.